TD Cowen ups Waters shares target, highlights pharma spending recovery By Investing.com

On Thursday, TD Cowen adjusted its outlook on Waters Corporation (NYSE:) shares, a laboratory instrument and software company. The firm raised its price target to $363 from the previous target of $325, while maintaining a Hold rating on the stock. This adjustment comes following Waters Corp ‘s second-quarter earnings call.

Waters Corp’s stock experienced a 2.5% increase after the earnings call. Management’s commentary suggested a positive shift in pharmaceutical spending, particularly in liquid chromatography (LC), and signs of a broader recovery in the China market.

Despite these optimistic indicators, Waters Corp has issued a conservative guide for 2024, citing the volatility experienced over the past year.

TD Cowen’s revised price target reflects an improved outlook for Waters Corp, as the firm aims to evaluate the opportunities within the liquid chromatography market and the potential financial impact on the company’s performance. The goal is to ascertain the possibility of further stock appreciation, especially considering the stock’s recent upward trajectory.

The company’s management has expressed a cautious stance for the upcoming year, adjusting their guidance to account for the unpredictability of market conditions. This conservative approach is seen as a response to the fluctuations that have characterized the past year’s performance.

Overall, the price target increase by TD Cowen suggests a more favorable view of Waters Corp’s future, despite the company’s own tempered expectations for 2024.

The firm’s analysis is looking to understand the extent to which the liquid chromatography segment can contribute to Waters Corp’s growth and strengthen its stock value moving forward.

In other recent news, Waters Corporation, a specialty measurement company, has presented an updated outlook for the third quarter and full year of 2024 during its recent earnings call.

Despite a continued decline in sales, the company reported resilient performance in the second quarter with several positive developments. The company’s full-year sales guidance for 2024 has been revised to a decline of -2% to -0.5%, with an adjusted operating margin of around 31%.

New product launches, such as the Xevo MRD and Acquity QDa II, have been well-received by customers, contributing to the company’s cautious yet optimistic outlook for the second half of the year. Additionally, Waters Corporation reported a Q2 organic constant currency sales decline of 4%, with orders outpacing sales.

TD Cowen, an independent financial firm, has adjusted its outlook on Waters Corporation, raising its price target on the company’s shares to $363 from the previous target of $325, while maintaining a Hold rating on the stock.

This adjustment follows Waters Corporation’s second-quarter earnings call and reflects an improved outlook for the company. Despite the company’s conservative guide for 2024, the firm’s revised price target suggests a more favorable view of Waters Corporation’s future.

InvestingPro Insights

As Waters Corporation (NYSE:WAT) navigates a landscape marked by cautious optimism and conservative guidance, real-time data from InvestingPro provides additional context for investors. The company’s recent performance indicates a significant return over the last week, with a 1 Week Price Total Return of 8.38%. Additionally, Waters Corp’s stock is trading near its 52-week high, currently at 94.62% of this peak value, reflecting a strong market sentiment.

InvestingPro Tips highlight that while analysts have revised their earnings downwards for the upcoming period, the company still operates with a moderate level of debt and has liquid assets that exceed short-term obligations. This suggests a level of financial stability that may reassure investors. Moreover, Waters Corp’s stock generally trades with low price volatility, providing a relatively steady investment option.

For those considering an investment in Waters Corp, it is worth noting that the company is trading at a high Price / Book multiple of 14.49 and a high EBITDA valuation multiple, as per the last twelve months as of Q2 2024. These metrics, along with the company’s recent performance, could be pivotal in shaping investor decisions.

InvestingPro offers a wealth of additional tips and insights for Waters Corporation, which can be accessed at Investing.com/pro/WAT. With 13 more InvestingPro Tips available, investors can gain a deeper understanding of the company’s financial nuances and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.